Skip to search boxSkip to navigationSkip to main content

IDO expression by dendritic cells: Tolerance and tryptophan catabolism

*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Peer-review

Abstract

Indoleamine 2,3-dioxygenase (IDO) is an enzyme that degrades the essential amino acid tryptophan. The concept that cells expressing IDO can suppress T-cell responses and promote tolerance is a relatively new paradigm in immunology. Considerable evidence now supports this hypothesis, including studies of mammalian pregnancy, tumour resistance, chronic infections and autoimmune diseases. In this review, we summarize key recent developments and propose a unifying model for the role of IDO in tolerance induction.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 762-774 (13 pages)

Journal (Volume, Issue Number)

Nature Reviews Immunology (Volume 4, Issue 10)

Publication milestones

  • Published - 10/2004

Publication status

Published - 10/2004

ISSN

1474-1733

Publication IDs

  • Scopus: 5044220930
  • PubMed: 15459668

Publication metrics

Metrics

SciVal
FWCI
13.02
SciVal
Author count
2
SciVal
citations
1703
SciVal
Paper percentile
99
SciVal
Top percentile
1
Scopus
citations
Fractional count
2
Fractional count
1
Fractional count
2
Fractional count
1

PlumX, opens in new tab

Captures
1075
Citation count
2125
Mentions
2

Funding Details

We acknowledge the National Institutes of Health for supporting the research described in this review.